Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 5, 2007, Pages 867-873

  Procelewska, Malgorzata ^a   Kolcz, Jacek ^a   Januszewska, Katarzyna ^a   Mroczek, Tomasz ^a   Malec, Edward ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Coagulation abnormalities; Fontan operation; Liver dysfunction; Thromboembolic complications

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN; PROTHROMBIN; PLASMA PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CENTRAL VENOUS PRESSURE; CHILD; CONTROLLED STUDY; FONTAN PROCEDURE; HEART VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; LIVER DYSFUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; THROMBOEMBOLISM; BLOOD; BLOOD PRESSURE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; HEART VENTRICLE; INFANT; LIVER; LIVER FUNCTION TEST; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BLOOD COAGULATION DISORDERS; BLOOD PRESSURE; BLOOD PROTEINS; FACTOR VII; FACTOR VIII; FIBRINOGEN; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; LIVER; LIVER FUNCTION TESTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBOEMBOLISM;

EID: 34047143271     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.01.033     Document Type: Article

References (25)

1. Fontan F., and Baudet E. Surgical repair of tricuspid atresia. Thorax 26 (1971) 240-248
2. Jacobs M.L. The Fontan operation, thromboembolism, and anticoagulation: a reappraisal of the single bullet theory. J Thorac Cardiovasc Surg 129 (2005) 491-495
3. Monagle P., Cochrane A., McCrindle B., Benson L., Williams W., and Andrew M. Thromboembolic complications after Fontan procedure - the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 115 (1998) 493-498
4. Gupta A., Daggett C., Behera S., Ferraro M., Wells W., and Starnes V. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. J Thorac Cardiovasc Surg 127 (2004) 1664-1669
5. Mertens L., Hagler D.J., Sauer U., Somerville J., and Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg 115 (1998) 1063-1073
6. Fontan F., Kirklin J.W., Fernandez G., Costa F., Naftel D.C., Tritto F., and Blackstone E.H. Outcome after a "perfect" Fontan operation. Circulation 81 (1990) 1520-1536
7. Cromme-Dijkhuis A.H., Henkens C.M., Bijleveld C.M., Hillege H.L., Bom V.J., and van der Meer J. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operation. Lancet 336 8723 (1990) 1087-1090
8. Jahangiri M., Kreutzer J., Zurakowski D., Bacha E., and Jonas R.A. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. J Thorac Cardiovasc Surg 120 (2000) 778-782
9. Jahangiri M., Shore D., Kakkar V., Lincoln C., and Shinebourne E. Coagulation factor after Fontan procedure and its modifications. J Thorac Cardiovasc Surg 113 (1997) 989-993
10. Douville E.C., Sade R.M., and Fyfe D.A. Hemi-Fontan operation in surgery for single ventricle: a preliminary report. Ann Thorac Surg 51 (1991) 893-899
11. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F., and Mitchell L. Maturation of the hemostatic system during childhood. Blood 80 (1992) 1998-2005
12. Mitchell I.M. Liver function after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg 110 1 (1995) 284-286
13. van Nieuwenhuizen R.C., Peters M., Lubbers L.J., Trip M.D., Tijssen J.G.P., and Mulder B.J.M. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart 82 (1999) 40-46
14. Odegard K.C., McGowan F.X., DiNardo J.A., Castro R.A., Zurakowski D., Connor C.M., Hansen D.D., Neufeld E.J., del Nido P.J., and Laussen P.C. Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure. J Thorac Cardiovasc Surg 123 (2002) 459-465
15. Odegard K.C., McGowan F.X., Zurakowski D., DiNardo J.A., Castro R.A., del Nido P.J., and Laussen P.C. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 73 (2002) 1770-1777
16. Cheung E.W., Chay G.W., Ma E.S., and Cheung Y.F. Systemic oxygen saturation and coagulation factor abnormalities before and after the Fontan operation. Am J Cardiol 96 11 (2005) 1571-1575
17. Chan A.K., Leaker M., Burrows F.A., Williams W.G., Gruenwald C.E., Whyte L., Adams M., Brooker L.A., Adams H., Mitchell L., and Andrew M. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 77 2 (1997) 270-277
18. Turner-Gomes S.O., Mitchell L., Williams W.G., and Andrew M. Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 107 2 (1994) 562-568
19. Zivelin A., Tao L.V.M., and Rapaport S.I. Mechanism of the anticoagulation effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin k-dependent clotting factors. J Clin Invest 92 (1993) 2131-2140
20. Rapaport S.I., and Rao M.V. The time factor pathway: How it has become a "Prima Ballerina". Thromb Haemost 74 (1995) 7-17
21. O'Donnell J., Tuddenham E.G., Manning R., Kemball-Cook G., Johnson D., and Laffan M. High prevelance of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 77 (1997) 825-828
22. Odegard K.C., McGowan F.X., Zurakowski D., DiNardo J.A., Castro R.A., del Nido P.J., and Laussen P.C. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. J Thorac Cardiovasc Surg 125 (2003) 1260-1267
23. Rauch R., Ries M., Hofbeck M., Buheitel G., Singer H., and Klinge J. Hemostatic Changes following the modified Fontan operation (total cavopulmonary connection). Thromb Haemost 83 (2000) 678-682
24. Koster T., Blann A.D., Briet E., Vanderbroucke J.P., and Rosendaal F.R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345 (1995) 152-155
25. Hollestelle M.J., Thinnes T., Crain K., Stico A., Kruijt J.K., van Berkec T.J.C., Loskutoff D.J., and van Mourik J.A. Tissue distribution of factor VIII gene expression in vivo - a closer look. Thromb Haemost 86 (2001) 855-861